Results 231 to 240 of about 3,209,064 (352)
Ancient Chinese Character Recognition with Improved Swin-Transformer and Flexible Data Enhancement Strategies. [PDF]
Zheng Y, Chen Y, Wang X, Qi D, Yan Y.
europepmc +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Adapting multilingual vision language transformers for low-resource Urdu optical character recognition (OCR). [PDF]
Cheema MDA +4 more
europepmc +1 more source
HANDWRITTEN CHARACTER RECOGNITION
openaire +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
CBD2023: A Hypercomplex Bangla Handwriting Character Recognition Data for Hierarchical Class Expansion. [PDF]
Bappi JO, Rony MAT.
europepmc +1 more source
A comparison study between MLP and convolutional neural network models for character recognition
Syrine Ben Driss +3 more
semanticscholar +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
SMS Scam Detection Application Based on Optical Character Recognition for Image Data Using Unsupervised and Deep Semi-Supervised Learning. [PDF]
Shinde A +5 more
europepmc +1 more source

